Malaysia is an upper middle income country that provides subsidized healthcare to ensure universal coverage to its citizens. The challenge of escalating health care cost occurs in most countries, including Malaysia due to increase in disease prevalence, which induced an escalation in drug expenditure. In 2009, the Ministry of Health has allocated up to Malaysian Ringgit (MYR) 1.402 billion (approximately USD 390 million) on subsidised drugs. This study was conducted to measure patients’ willingness to pay (WTP) for treatment of chronic condition or acute illnesses, in an urbanized population.
A cross-sectional study, through face-to-face interview was conducted in an urban state in 2012–2013. Systematic random sampling of 324 patients was selected from a list of patients attending ten public primary cares with Family Medicine Specialist service. Patients were asked using a bidding technique of maximum amount (in MYR) if they are WTP for chronic or acute illnesses.
Patients are mostly young, female, of lower education and lower income. A total of 234 respondents (72.2%) were not willing to pay for drug charges. WTP for drugs either for chronic or acute illness were at low at median of MYR10 per visit (USD 3.8). Bivariate analysis showed that lower numbers of dependent children (≤3), higher personal and household income are associated with WTP. Multivariate analysis showed only number of dependent children (≤3) as significant (p = 0.009; 95% CI 1.27–5.44) predictor to drugs’ WTP.
The result indicates that primary care patients have low WTP for drugs, either for chronic condition or acute illness. Citizens are comfortable in the comfort zone whereby health services are highly subsidized through universal coverage. Hence, there is a resistance to pay for drugs.
Annual report: Malaysian Ministry of Health. Kuala Lumpur: Pharmaceutical Services Division; 2005.
Annual report: Malaysia Ministry of Health drug expenditure. Kuala Lumpur: Pharmaceutical Services Division; 2010.
Hussain HS. Drug control and formulary management in Malaysia. Pharmacoecon Outcomes Res Asia. 2008;11:S158–9.
Bridel A. Explaining 1Care: its proposals, rationale and feasibility. Philippines: Center for Public Policy Studies (CPPS); 2012.
Quevedo JFM, Hernández IC, Espinosa JG, Escudero GS. The willingness-to-pay concept in question. Rev Saúde Pública. 2009;43:2.
Adeneye AK, Mafe MA, Appelt B, Idowu ET, Akande DO. Willingness to pay for praziquantel treatment in a hyper-endemic community of Ogun State, Nigeria. Res Soc Adm Pharm. 2006;2:83–95. CrossRef
Michael AM, Bohara AK, Pagán JA. Assessing willingness to pay for cancer prevention. Int J Health Care Finance Econ. 2010;10:301–14. CrossRef
Jones R, White P, Armstrong D, Ashworth M, Peters M. Managing acute illness. The King’s Fund. 2010.
Population distribution and basic demographic characteristic report 2010. Department of Statistics Malaysia. 2010. http://www.statistics.gov.my. Accessed 11 Jan 2013.
Engelgau M, Rosenhouse S, El-Saharty S, Mahal A. The economic effect of non-communicable diseases on households and nations: a review of existing evidence. J Commun Healthc. 2011;16(Suppl. 2):75–81. CrossRef
Pinto SL, Pharm BS, Goodman MH, Black CD, Lesch D. Identifying factors that affect patients’ willingness to pay for inhaled insulin. Adm Pharm. 2009;5:253–61. CrossRef
Okyere WKA, Akoto IO, Anum A, Appiah EN. Willingness to pay for health insurance in a developing economy: a pilot study of the informal sector of Ghana using contingent valuation. Health Policy. 1997;42:223–37. CrossRef
Clinical practice guidelines. Management of type 2 diabetes mellitus. 4th ed. Kuala Lumpur: Persatuan Diabetes Malaysia, Academy of Medicine Malaysia, Ministry of Health Malaysia; 2009.
Consumer price guide. Pharmaceutical Services Division, Ministry of Health Malaysia. 2014. http://www.pharmacy.gov.my/v2/ms/apps/drug-price. Accessed 11 Jan 2013.
Millar WJ. Patterns of use–alternative health care practitioners. Health Rep. 2001;13(1):9–21. PubMed
- Patients’ willingness to pay for their drugs in primary care clinics in an urbanized setting in Malaysia: a guide on drug charges implementation
Sharifa Ezat Wan Puteh
Siti Nurul Akma Ahmad
Azimatun Noor Aizuddin
- BioMed Central
Neu im Fachgebiet Allgemeinmedizin
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II